Delivery Order SPE2DB20D1100-SPE2DB24FC7F3

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,367.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication, to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $12,780.62 Firm Fixed Price Delivery Order is for the supply of Gilenya 0.5 MG Capsules, a prescription medication. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This serves as the primary...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,867.54 firm fixed-price delivery order is for the supply of the prescription drug Gilenya 0.5 mg capsules. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a part of the U.S. Department of Defense (DoD). The contract, valued at $8,002.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Gilenya 0.5 mg capsules, a prescription medication, to support DoD and other government healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,201.68 firm fixed price delivery order is for the supply of the prescription drug Gilenya 0.5 mg capsules, with a performance period through June 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $41,555.95 and a term ending on June 11, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The $16,476.49 firm fixed-price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gilenya 0.5 mg capsules. The contract has a ceiling value of $26,277.64 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $23,656.42 Firm Fixed Price delivery order is for the pharmaceutical product Gilenya 0.5 mg capsules. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7F3
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $46,518.40 firm fixed price delivery order is for the provision of Gilenya 0.5 mg capsules. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025 to deliver a wide range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This particular award does not have a set-aside designation.

Generated 10/11/24, 9:37 AM